UBS Group’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
UBS Group's ADNT Position: Q3 2026 in Review
UBS Group reduced its Adient (ADNT) stake by 4.9% in Q3 2026, selling an estimated $1.62M and leaving 1,619,475 shares worth $27.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2325.
UBS Group first reported a position in ADNT in Q4 2016 and has held it in 40 quarters since. The position peaked at $77.2M in Q1 2018. 304 funds tracked by Wall St. Rank hold ADNT as of Q3 2026.
- UBS Group held 1,619,475 shares of Adient worth $27.3M as of Q3 2026.
- UBS Group sold 83,878 Adient shares in Q3 2026, an estimated $1.62M.
- Adient made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2325 holding.
- UBS Group first reported a position in Adient in Q4 2016 and has held it in 40 quarters since.
- UBS Group's Adient position peaked at $77.2M in Q1 2018.
- 304 funds tracked by Wall St. Rank held Adient as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.